Physician profile

Michael Mitry

Foot & Ankle Surgery · Needham, MA

NPI 1700193406

$1,533.92

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$16.56

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Paragon 28, INC. $1,335.86 2019
Smith+Nephew, INC. $59.11 2019-2021
Fidia Pharma USA INC. $37.68 2019-2020
Stryker Corporation $32.23 2019
Pfizer INC. $27.20 2019-2020
Medshape, INC. $16.56 2023 Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm
Wright Medical Technology, INC. $13.90 2019
Dynasplint Systems INC. $11.38 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Mitry

$1,533.92

in general payments reported 2019-2025

Years
2019-2023
Top company
Paragon 28, INC.

https://glasscript.com/doctor/77574/michael-mitry

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.